4-Chloro-3-nitro-tert-butylbenzene, 90.0%, 5g

(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester, 98%, 25g

Methyl 5-bromo-4-hydroxynicotinate, 95.0%, 1g

2-Methyl-2-propanyl 4-nitro-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene-11-carboxylate, 98%, 100mg

Balance à plate-forme série IFB Modèles non certifiés, 0,5 g, 15 000 g, IFB 10K-4

Oculaire grand angle WF 10x/20 mm, tube Ø 30 mm

4-Acetylthiazole, 98.0%, 25g

2-bromo-N-(4-ethoxyphenyl)acetamide, 250mg

2-Acetamido-4-methylthiazole-5-sulfonyl Chloride>98.0%(HPLC)(T)1g

1,3,3-Trimethyl-6'-(piperidin-1-yl)spiro[indoline-2,3'-naphtho[2,1-b][1,4]oxazine], 97%, 1g

Gélatine, 1 kg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((bis(methylamino)methylene)amino)pentanoic acid, 97%, 1g

2-Chloro-5,6-dihydro-7H-cyclopenta[b]pyridin-7-one, 97%, 10g